Mohan Bala, SVP, Chief Development Officer: Mersana Therapeutics MRSN Sell · Filed 25/01/15

Trade details

Type: Insider sale
Amount: $2,146.98
Shares · price: 3,253 sh · $0.66 a share
Held after: 60,228 sh
Stock: Mersana Therapeutics MRSN
Person: Mohan BalaSVP, Chief Development Officer
Trade date: 25/01/14
Filed: 25/01/15
Days to filing: 1 days

Sold 5.1% of holdings

Share of holding sold: 5.1%

Mersana Therapeutics trades, last 26 weeks

What else happened in Mersana Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/15~25/02/13

Mohan Bala's recent trades

Mohan BalaSVP, Chief Development Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$762
77 sh
$762
Filed 25/10/28
Traded 25/10/27
Mohan BalaSVP, Chief Development Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$3,445
5,939 sh
$3,445
Filed 25/01/17
Traded 25/01/16
Mohan BalaSVP, Chief Development Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$3,580
1,884 sh
$3,580
Filed 24/10/29
Traded 24/10/28
Mohan BalaSVP, Chief Development Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$16.2K
8,089 sh
$16.2K
Filed 24/10/07
Traded 24/10/02
Mohan BalaSVP, Chief Development Officer
Sell10b5-1 planMersana Therapeutics
Sell10b5-1 plan
Mersana Therapeutics
MRSN
$11K
5,598 sh
$11K
Filed 24/10/07
Traded 24/10/03

Mohan Bala, Chief Officer — sold $2,147 of Mersana Therapeutics MRSN · 5.1% of holdings · 10b5-1 plan | Whalegun